Assessment of autologous blood marker localization and intraoperative colonoscopy localization in laparoscopic colorectal cancer surgery (ability): a randomized controlled trial

HIGHLIGHTS

• who: Ke-hui Zhang from the The trial is designed as a randomized, controlled, single center no inferiority trial with two parallel groups and a primary endpoint of localization accuracy during laparoscopic colectomy, which will take place in the Department of Gastrointestinal Surgery, Shanghai East Hospital, Tongji University, Shanghai, China (Fig1). The participants will be screened for inclusion and exclusion criteria (Table, ) by the reception oncologist. Eligible patients will be invited for study participation at their first visit at Department of Gastrointestinal Surgery. The doctor who sees the patient will give a formal and detailed description of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.